These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Late radiation effects of low doses from occupational exposure. Antibodies to cytomegalovirus, Epstein-Barr virus and human T cell lymphotropic virus type 1 in radiological technologists]. Kumagai E; Tanoue S; Sawada S Rinsho Byori; 1989 May; 37(5):577-83. PubMed ID: 2549288 [No Abstract] [Full Text] [Related]
3. [Late radiation effects of low doses from occupational exposure. Epstein-Barr virus-related antibody titers in radiological technologists]. Kumagai E; Higashida Y; Onomichi M; Tanaka R; Kumagai T; Katsuki T; Sawada S Rinsho Byori; 1985 Dec; 33(12):1451-6. PubMed ID: 3007814 [No Abstract] [Full Text] [Related]
4. Study of the titers of anti-Epstein-Barr virus antibodies in the sera of atomic bomb survivors. Akiyama M; Kusunoki Y; Kyoizumi S; Ozaki K; Mizuno S; Cologne JB Radiat Res; 1993 Mar; 133(3):297-302. PubMed ID: 8383861 [TBL] [Abstract][Full Text] [Related]
5. Age distribution of Epstein-Barr virus, cytomegalovirus and rubella virus antibodies. Lin KH; Chiang CH; Yang CS Taiwan Yi Xue Hui Za Zhi; 1987 Dec; 86(12):1316-9. PubMed ID: 2832515 [No Abstract] [Full Text] [Related]
6. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. Amsterdam JD; Henle W; Winokur A; Wolkowitz OM; Pickar D; Paul SM Am J Psychiatry; 1986 Dec; 143(12):1593-6. PubMed ID: 3024514 [TBL] [Abstract][Full Text] [Related]
8. Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis. Riverol M; Sepulcre J; Fernandez-Diez B; Villoslada P; Fernandez-Alonso M; Rubio M; Rodriguez A; Uccelli A; Brieva L J Neuroimmunol; 2007 Dec; 192(1-2):184-5. PubMed ID: 17869349 [No Abstract] [Full Text] [Related]
9. [Relationship between the clinical subtype and Epstein-Barr virus specific antibodies in patients with adult T-cell leukemia]. Kumagai E; Kumagai T; Tanaka R; Tanoue S; Katsuki T; Asou N; Yamaguchi K; Takatsuki K Rinsho Ketsueki; 1987 Aug; 28(8):1403-8. PubMed ID: 2892949 [No Abstract] [Full Text] [Related]
10. Antibodies to Epstein-Barr virus in 50 patients with thymic tumor. Perronne C; Ooka T; Decaussin G; De Thé G; Berrih-Aknin S; Verley JM JAMA; 1990 Aug; 264(5):570-1. PubMed ID: 2164111 [No Abstract] [Full Text] [Related]
11. Epstein-Barr virus specific antibodies in patients with coeliac disease. Harada S; Greally J; Davis J; Synder N; Stevens F; McCarthy C; Purtilo DT Ir J Med Sci; 1985 Nov; 154(11):416-21. PubMed ID: 3005191 [No Abstract] [Full Text] [Related]
12. [Fluctuation in Epstein-Barr virus-related antibody titers by age: response differences between the IgG antibodies to VCA and anti-EBNA antibodies]. Kumagai E; Tanaka R; Kumagai T; Katsuki T; Sawada S Rinsho Byori; 1984 Jun; 32(6):666-70. PubMed ID: 6092744 [No Abstract] [Full Text] [Related]
13. [The Epstein-Barr virus and tonsilar carcinoma in clinical practice]. Síbl O; Brichácek B; Hirsch I; Suchánková A; Vonka V Cas Lek Cesk; 1982 Nov; 121(47):1445-8. PubMed ID: 6295630 [No Abstract] [Full Text] [Related]
14. Antibodies to cytomegalovirus, Herpes simplex virus and Epstein-Barr virus in Greek blood donors. Kavallierou L; Bezirtzoglou E; Kapellou P; Spanaki S; Renieri N Med Lab Sci; 1991 Apr; 48(2):142-6. PubMed ID: 1658527 [TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr-virus-antibodies and lymphocytotoxic serum-antibodies in patients with sarcoidosis]. Becker FW; Gallmeier WM; Hertenstein C; Kalden JR Klin Wochenschr; 1972 Oct; 50(19):927-8. PubMed ID: 4343096 [No Abstract] [Full Text] [Related]
16. [The characteristics of the immunologic response to Epstein-Barr virus in patients with cancer of the larynx]. Isaeva TM; Choĭnzonov EL; Ruzaev LN; Podoplekin VD Vestn Otorinolaringol; 1988; (2):51-4. PubMed ID: 2838946 [No Abstract] [Full Text] [Related]
17. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma. Hsu MM; Chen JY; Chen CJ Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721 [No Abstract] [Full Text] [Related]
18. Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250. Jilg W; Wolf H J Infect Dis; 1985 Jul; 152(1):222-5. PubMed ID: 2989385 [No Abstract] [Full Text] [Related]